Lori D. Dwyer‐Nield

Medicine · Health Sciences

29h-index2.9kcitations107works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neonatal Respiratory Health Research(14), Inflammatory mediators and NSAID effects(14), RNA modifications and cancer(14), Lung Cancer Treatments and Mutations(13), Epigenetics and DNA Methylation(11)

Publications107 total

Data from Growth Inhibition and Regression of Lung Tumors by Silibinin: Modulation of Angiogenesis by Macrophage-Associated Cytokines and Nuclear Factor-κB and Signal Transducers and Activators of Transcription 3
2023Open Access
Supplementary Figure Legend from Growth Inhibition and Regression of Lung Tumors by Silibinin: Modulation of Angiogenesis by Macrophage-Associated Cytokines and Nuclear Factor-κB and Signal Transducers and Activators of Transcription 3
2023Open Access
Table S2 from A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers
2023Open Access
Supplementary Table Legend from A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers
2023Open Access
Supplementary Figure 1 from Growth Inhibition and Regression of Lung Tumors by Silibinin: Modulation of Angiogenesis by Macrophage-Associated Cytokines and Nuclear Factor-κB and Signal Transducers and Activators of Transcription 3
2023Open Access
Supplementary Figure Legend from Growth Inhibition and Regression of Lung Tumors by Silibinin: Modulation of Angiogenesis by Macrophage-Associated Cytokines and Nuclear Factor-κB and Signal Transducers and Activators of Transcription 3
2023Open Access
Data from Growth Inhibition and Regression of Lung Tumors by Silibinin: Modulation of Angiogenesis by Macrophage-Associated Cytokines and Nuclear Factor-κB and Signal Transducers and Activators of Transcription 3
2023Open Access
Supplementary Figure S1 from The Second-Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma Model
2023Open Access
Table S2 from A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers
2023Open Access
Data from A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers
2023Open Access
Supplementary Figure S1 from The Second-Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma Model
2023Open Access
Supplementary Table Legend from A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers
2023Open Access
Data from The Second-Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma Model
2023Open Access
Data from A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers
2023Open Access
Data from The Second-Generation PGI2 Analogue Treprostinil Fails to Chemoprevent Tumors in a Murine Lung Adenocarcinoma Model
2023Open Access
Table S1 from A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers
2023Open Access
Supplementary Figure 1 from Growth Inhibition and Regression of Lung Tumors by Silibinin: Modulation of Angiogenesis by Macrophage-Associated Cytokines and Nuclear Factor-κB and Signal Transducers and Activators of Transcription 3
2023Open Access
Table S1 from A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers
2023Open Access
Data from Altered Cell-Cycle Control, Inflammation, and Adhesion in High-Risk Persistent Bronchial Dysplasia
2023Open Access
Supplementary data, tables and figures from Altered Cell-Cycle Control, Inflammation, and Adhesion in High-Risk Persistent Bronchial Dysplasia
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Alvin M. Malkinson(40), Robert L. Keith(13), Alison K. Bauer(10), Mark W. Geraci(8), Amy M. Meyer(8), Daniel T. Merrick(6), Meredith A. Tennis(6), Elizabeth F. Redente(6), Laura K. Zerbe(5), Rajesh Agarwal(5), Paul A. Bunn(4), Wilbur A. Franklin(4), Rana P. Singh(4), Jason M. Fritz(4), Pamela L. Rice(4), Lori R. Kisley(4), David C. Thompson(4), John A. Thompson(4), Robert S. Stearman(3), David Dinsdale(3)